
Emergency department visits for cannabis-related vomiting have increased dramatically, often fivefold, since 2016.
Story Snapshot
- The condition, known as cannabinoid hyperemesis syndrome (CHS), is marked by cyclical, intractable vomiting and abdominal pain, often relieved only by hot showers and cannabis cessation.
- Young, heavy daily users are most at risk, with many requiring repeated ER visits and hospitalizations.
- Despite cannabis’ reputation as an anti-nausea remedy, CHS is a paradoxical effect seen in chronic, high-potency users.
- Recognition and diagnosis remain inconsistent, leading to unnecessary tests and prolonged suffering.
The Rise of CHS
Cannabinoid hyperemesis syndrome first emerged in medical literature in the early 2000s, but it was considered rare. As cannabis potency and daily use have surged, so have cases of CHS. Emergency departments now report a sharp increase in young adults presenting with severe, recurrent vomiting that does not respond to typical anti-nausea treatments. The hallmark of CHS is the compulsive need for hot showers or baths, which temporarily relieves symptoms. Only complete cessation of cannabis use reliably stops the episodes, but many patients and clinicians still fail to recognize the connection.
Watch:
Who Is Most at Risk?
The typical CHS patient is a young adult or older teen who has used cannabis daily for several years, often multiple times per day. Most cases involve high-THC products, including concentrates and edibles. The syndrome rarely appears in occasional users or those who started cannabis use later in life. The risk rises with both frequency and duration of use, and symptoms can persist for years if cannabis use continues. Many patients report multiple ER visits before receiving a correct diagnosis, often undergoing unnecessary imaging and lab tests.
Find out what is causing your nausea today.
Impact on Emergency Care
CHS is now a significant burden on emergency departments, especially in states with high cannabis use. Episodes can be severe enough to cause dehydration, electrolyte imbalances, and even organ failure if untreated. The financial and emotional toll on patients and families is substantial, with repeated hospitalizations and lost productivity. Clinicians are increasingly aware of CHS, but under-diagnosis remains a problem, as symptoms are often mistaken for gastroenteritis or psychiatric conditions. The only proven treatment is cannabis cessation, but many patients struggle to quit due to addiction or lack of awareness. Talk to your AI doctor – safe, simple, and free.
Public Health and Policy Implications
The rise of CHS complicates the narrative that cannabis is a benign or therapeutic substance. As legalization spreads and high-potency products become more common, public health officials and policymakers face tough questions about labeling, potency limits, and education campaigns. Some experts argue for targeted warnings on high-THC products, especially those marketed to young adults. Others stress the need for better provider training and screening protocols in emergency settings. The cannabis industry may face pressure to acknowledge CHS risks, but debates continue over how best to balance harm reduction with access to legal cannabis.
Get instant support for vomiting or motion sickness.
Sources:
Painful Syndrome Sending Cannabis Users to ER: Are You at Risk?
The Strange Rise of Scromiting: Most Common Among Young Heavy Cannabis Users
Chronic Cannabis Vomiting, Compulsive Symptoms
JAMA Network Open: Cannabis Hyperemesis Syndrome
PMC: Cannabis Hyperemesis Syndrome and Emergency Department Visits

















